BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology

Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...

February 04, 2022 | News

iMediSync Successfully Launches the Future of Tele-Medicare at CES 2022

iMediSync, A biotech startup company from Seoul, South Korea, successfully debuted at CES 2022 to introduce the new trend of digital healthc...

January 28, 2022 | News

Biogen to acquire full ownership of Samsung Bioepis

Agreement with Biogen to buyout Biogen's (50% -1 share) stake in Samsung Bioepis Joint Venture for up to USD $2.3 billion Transaction projected to ...

January 28, 2022 | News

Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug

Daewoong Pharmaceutical (Daewoong) has confirmed promising phase 3 topline results that focuses on the therapeutic effects as an Enavogliflozin monotherapy...

January 26, 2022 | News

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

Q4'21 revenue of KRW 444.3 billion increased 18% compared to Q4'20. Q4'21 operating profit of KRW 128.8 billion increased 39% compar...

January 25, 2022 | News

WuXi Biologics completes the first GMP inspection in 2022

WuXi Biologics a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by&n...

January 18, 2022 | News

Seegene Unveils Blueprint for the Future of Molecular Diagnostics

Along with three solutions, he also introduced the company's automated, AI-enabled platform with a standard development tool that will empower users to eas...

January 13, 2022 | News

Samsung Biologics Shares Strategic Roadmap for Sustainable Growth

During the main track presentation today, John Rim, President and CEO of Samsung Biologics, addressed the company's vision for 2022 and business goals...

January 13, 2022 | News

SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease

ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a pro...

January 12, 2022 | News

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

LISCure has been conducting joint research with Mayo Clinic for NASH drugs since 2021, and this new collaboration is an agreement signed under the leadersh...

January 07, 2022 | News

GC Cell seeks to expand global availability of Immuncell-LC® for liver cancer

Rivaara Immune to lead development and commercialization in India GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they hav...

January 05, 2022 | News

Celltrion plans to provide dual treatment options for COVID-19 in South Korea

CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron var...

January 04, 2022 | News

WuXi Biologics, ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody

Within the partnership, ImmuneOncia will have access to WuXi Biologics' integrated services in cell line development, cell culture development, biologics m...

December 28, 2021 | News

Curocell, Breaks Ground on 'CAR-T Manufacturing GMP Facility'

The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-met...

December 24, 2021 | News

Stay Connected